G6PD and hyperinsulinemic hypoglycemia, familial, 4: Although studies in Burkina Faso showed that methylene blue is unlikely to be responsible for clinically relevant haemolysis in individuals with or without G6PD-deficiency,29 additional studies are needed on the safety of methylene blue among G6PD-deficient individuals.